Skip to content

CLINICAL EFFICACY OF SPARK IN THE MANAGEMENT OF OLIGOZOOSPERMIA AND ASTHENOZOOSPERMIA

EVALUATION OF CLINICAL EFFICACY OF CAPSULE SPARK IN THE MANAGEMENT OF OLIGOZOOSPERMIA AND ASTHENOZOOSPERMIA

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/09/007298
Enrollment
60
Registered
2016-09-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- established cases of Oligozoospermia and Asthenozoospremia

Interventions

Intervention1: capsule 2-0-2 before food: Ashvagandha, Kapikachu, Gokshur, Shatavari, Vidarikand, Jatiphala, Bala, Narsinha, Shveta Musali, Shuddha Shilajatu, Maricha, Shunthi ,Pippali Intervention2:

Sponsors

VASU Health Care Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 20 45 years of male Sperm count below 15 million ml according to WHO 2010 Patient with clinical presentation of Ksheenashukra Oligozoospermia and Asthenozoospremia Daurbalya Klaibya Shukra Avisarga Pandu etc

Exclusion criteria

Exclusion criteria: Age below 21 and above 50 years. Sperm count more than 15 million per ml Patient of azoospermia and aspermia Patients of various diseases like varicocele accessory sex gland infection, sexually transmitted diseases severe systemic diseases etc.Genetic disorders like Klinfelters syndrome Taking treatment for major psychiatric problem

Design outcomes

Primary

MeasureTime frame
Effect on subjective parameters like, Sexual desire, Erection, Rigidity, Performance anxiety, Ejaculation, Orgasm and post act exhaustion will be assessedTimepoint: Improvement in the semenogram will be observed especially in total sperm count. Change in S. FSH, S. LH, S. Testosterone will also be evaluated before and after treatment.

Secondary

MeasureTime frame
Overall improvement in the condition, Quality of Life of the individual will be assessed. Based on the observations, a large scale study involving larger populations may be attempted.Timepoint: 2 Months

Countries

India

Contacts

Public ContactDR ANUP THAKAR

Institute for Post Graduate Teaching and Research in Ayurveda

anup_thakar@yahoo.com9427776660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026